Answers are grounded in this paper and cite their sources.
: Inhibiting KDM1A could attack aggressive neuroblastomas two-fold, by re-directing tumor cells toward a less aggressive, slower-growing phenotype and by preventing or reducing the vascular support of large tumors.
No takes yet. Share an insight, caveat, or question.
Sprüssel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: